Wednesday, February 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Insights and Ratings on CubeSmart March 4 2024

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
DVY stock news
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Insights from Analyst Ratings on CubeSmart as of March 4, 2024

—

CubeSmart (NYSE:CUBE) has recently undergone evaluation by analysts, revealing a range of perspectives from bullish to bearish. Here are the key takeaways from the latest analyst ratings:

Total Ratings: A total of 7 ratings were provided by analysts, consisting of 1 bullish, 1 somewhat bullish, 4 indifferent, 0 somewhat bearish, and 1 bearish.

Price Targets: Analysts have set 12-month price targets for CubeSmart, with an average target of $45.43. The high estimate is $53.00, and the low estimate is $40.00. The current average target represents a 9.47% increase from the previous average price target.

Recent Analyst Actions:

– Steve Sakwa from Evercore ISI Group upgraded the rating to In-Line, setting a price target of $45.00.
– Omotayo Okusanya from Deutsche Bank issued a Sell rating with a price target of $40.00.
– Jonathan Petersen from Jefferies upgraded the rating to Buy, setting a price target of $53.00.
– Ki Bin Kim from Truist Securities upgraded the rating to Hold, with a price target of $46.00.
– Juan Sanabria from BMO Capital upgraded the rating to Outperform, setting a price target of $49.00.
– Eric Luebchow from Wells Fargo upgraded the rating to Equal-Weight, with a price target of $42.00.

Analysts’ recommendations reflect their responses to market conditions and company performance, adjusting their stance based on recent developments concerning CubeSmart.

CUBE Stock Shows Strong Performance on March 4, 2024: Investors Confident in Companys Prospects

CUBE stock had a strong performance on March 4, 2024, as it traded near the top of its 52-week range and above its 200-day simple moving average. The stock closed at $44.59, which was a $0.99 increase from the previous market close, representing a 2.27% rise. This positive price momentum indicates that investors have confidence in the company’s performance and prospects. The fact that CUBE is trading near the top of its 52-week range suggests that there is strong demand for the stock, and investors are willing to pay a premium for it. Additionally, the stock’s performance on March 4, 2024, was particularly impressive as it remained unchanged in after-hours trading. This stability indicates that investors are holding onto their positions and are not rushing to sell off their shares. Overall, CUBE’s stock performance on March 4, 2024, reflects the company’s strong fundamentals and positive investor sentiment. It will be interesting to see if this momentum continues in the coming days and weeks. Investors should keep an eye on any developments related to the company that could impact its stock price.

CUBE Stock Shows Steady Performance with $1.05 Billion Revenue in 2023

On March 4, 2024, CUBE stock showed steady performance with total revenue of $1.05 billion for the past year and $265.12 million for the fourth quarter. The total revenue increased by 4.03% compared to the previous year and remained flat since the last quarter.

In terms of net income, CUBE reported $410.76 million for the past year and $112.67 million for the fourth quarter. The net income increased by 41.03% since last year and held flat since the last quarter.

Furthermore, the earnings per share (EPS) for CUBE stock were $1.82 for the past year and $0.50 for the fourth quarter. The EPS increased by 40.81% since last year and held flat since the last quarter.

Overall, the performance of CUBE stock on March 4, 2024, shows that the company has been able to maintain steady growth in revenue, profitability, and earnings per share. Investors may view this as a positive sign of the company’s financial health and may consider investing in CUBE stock based on its consistent performance.

Tags: CUBE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Navigating the Global Supply Chain: Challenges and Innovations in Zinc and Lead Extraction

The Success of Alamos Gold A Case Study in Compounded Returns and Market Outperformance

AI medical laboratory

Stereotaxis Reports Fourth Quarter 2023 Financial Results and Plans for Growth in 2024

Renewable energy

Eos Energy Enterprises Reports FourthQuarter 2023 Financial Results

Recommended

CleanSpark Stock

CleanSpark Navigates Record Profits and Regulatory Challenges

6 months ago
European Lithium Stock

Setback for European Lithium as Austrian Court Orders Fresh Environmental Review

2 months ago
Celularity Stock

Celularity Shares Extend Losses Despite Financial Restructuring

4 months ago
Juniper Networks Stock

Juniper Networks Integration Marks New Era for HPE

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

National Healthcare’s Financial Report: A Crucial Test Approaches

XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade

Coinbase Faces Mounting Pressure from Legal and Reputational Challenges

Terawulf Expands Infrastructure Portfolio with Major Site Acquisitions

Trending

NexPoint Residential Stock
Dividends

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

by Felix Baarz
February 4, 2026
0

Investors in NexPoint Residential Trust will receive a comprehensive update on the company's performance when it releases...

PC Connection Stock

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

February 4, 2026
Fossil Stock

Fossil Group Stock Surges Past Key Technical Threshold

February 4, 2026
NextGen Healthcare Stock

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

February 4, 2026
Arcus Biosciences Stock

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results
  • PC Connection Set to Report Full-Year and Fourth Quarter Earnings
  • Fossil Group Stock Surges Past Key Technical Threshold

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com